RegulatoryJun 17, 2026, 08:06 AM
Cibus Welcomes EU Decision to Treat Gene-Edited Crops as Conventional
AI Summary
Cibus, Inc. welcomed a landmark decision by the European Union to regulate crops improved without foreign DNA like conventionally bred crops, rather than transgenic GMOs. This ruling validates Cibus's nearly 25 years of development in precise, non-transgenic gene editing, opening the European market for its technology. The company's approach allows for faster development of traits like disease resistance and improved resource efficiency, reducing the need for chemicals. Cibus anticipates this decision will encourage similar regulatory changes globally, expanding opportunities for its partnerships with seed companies.
Key Highlights
- The EU will now treat crops improved without foreign DNA like conventionally bred crops, not transgenic GMOs.
- This decision opens the European market for Cibus's gene-edited crops, validating its 25-year development approach.
- Cibus's technology precisely edits a plant's own genes, delivering improved traits in about 12 months.
- Traits like disease resistance, water efficiency, and reduced chemical use qualify for the EU's non-GMO fast lane.
- Cibus expects this EU decision to encourage similar regulatory changes in other countries.
- Cibus's pod shatter reduction trait in winter oilseed rape is expected to qualify as Category 1 under new EU rules.
- Cibus partners with seed companies, adding improvements to their existing varieties and licensing them back for royalties.
- The framework allows seed companies to bring stronger, cleaner, multi-trait crops to market faster and at lower cost.
Price Impact
More from CBUS